SEMA3B was first described as a negative mediator of neuronal guidance by binding to neuropilin receptors, and it has been extensively studied as a tumor suppressor protein in various tumors, including lung and breast carcinoma, through the activation of apoptosis and inhibition of migration and tumor cell growth (12, 13). The gene discussed is PROS1; the disease is neoplasm.